Chargement en cours...
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
BACKGROUND: Imatinib mesylate is an effective treatment for metastatic gastrointestinal stromal tumor (GIST). However, most patients eventually develop resistance and there are few other treatment options. Immunotherapy using genetically modified or designer T cells (dTc) has gained increased attent...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3599052/ https://ncbi.nlm.nih.gov/pubmed/23433424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-46 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|